Angiotensin-converting enzyme gene insertion/deletion polymorphism and left ventricular hypertrophy in hemodialysis...

Area of Science:

• Cardiology
• Nephrology
• Genetics

Background:

• Left ventricular hypertrophy (LVH) is a known complication in hemodialysis patients, often linked to volume overload and hypertension.
• The role of angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism in LVH has been explored in hypertension and cardiomyopathy, but its association with volume overload-induced LVH remains unclear.

Purpose of the Study:

• To investigate the association between the ACE gene I/D polymorphism and left ventricular hypertrophy in patients undergoing maintenance hemodialysis.
• To identify factors contributing to LVH in this patient population.

Main Methods:

• A study involving 80 maintenance hemodialysis patients was conducted.
• Multivariate regression analysis was used to assess the relationship between left ventricular mass index (LVMI) and various clinical factors, including ACE I/D genotype.

Main Results:

• LVMI was significantly associated with serum creatinine, male gender, antihypertensive drug treatment, interdialytic weight gain, and post-hemodialysis mean blood pressure.
• No significant association was found between LVMI and the ACE I/D genotype (p = 0.69).

Conclusions:

• The ACE gene I/D polymorphism does not appear to be a significant factor in the development of left ventricular hypertrophy in chronic hemodialysis patients.
• Hypertension and other complications related to renal failure are likely the primary drivers of LVH in this cohort.